EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Left Atrium Volume Reduction Procedure Concomitant With Cox-Maze Ablation in Patients Undergoing Mitral Valve Surgery: A Meta-Analysis of Clinical and Rhythm Outcomes

Massimo Baudo, Fabrizio Rosati, Lorenzo Di Bacco, Michele D'Alonzo, Stefano Benussi, Claudio Muneretto

Heart, Lung and Circulation · 2023

DOI: 10.1016/j.hlc.2023.09.009 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Heart, Lung and Circulation, 2023. Verfasst von Massimo Baudo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy. Electronic address: massimo.baudo@icloud.com. Hauptthemen laut MEDLINE: Heart Valve Diseases, Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The management of an enlarged left atrium (LA) in mitral valve (MV) disease with atrial fibrillation (AF) is still being debated. It has been postulated that a reduction in LA size may improve patient outcomes. This meta-analysis aimed to assess rhythm and clinical outcomes of combined surgical AF treatment with or without LA volume reduction (LAVR) in patients undergoing MV surgery. METHODS: A systematic review was performed and all available literature to May 2022 was included. The primary endpoint was analysis of early and late mortality and rhythm outcomes. Secondary outcomes included early and late cerebrovascular accident (CVA) and permanent pacemaker implantation. RESULTS: The search strategy yielded 2,808 potentially relevant articles, and 19 papers were eventually included. The pooled estimated rate of 30-day mortality was 3.76% (95% CI 2.52-5.56). The incidence rate of late mortality and late cardiac-related mortality was 1.75%/year (95% CI 0.63-4.84) and 1.04%/year (95% CI 0.31-3.53), respectively. At subgroup analysis when comparing the surgical procedure with and without AF ablation, the ablation subgroup showed a significantly lower rate of postoperative CVA (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve DiseasesAtrial FibrillationCatheter AblationHumansMitral ValveMaze ProcedureTreatment OutcomeHeart Atria

Stichwörter der Autor:innen

Atrial fibrillation ablationCardiac surgeryLeft atrium volume reduction surgeryMeta-analysisMitral valve surgery

Autor:innen und Institutionen

  • Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy. Electronic address: massimo.baudo@icloud.com.
  • Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Förderung

  • Medtronic

Zitieren

APA

Baudo, M., Rosati, F., Di Bacco, L., D'Alonzo, M., Benussi, S., & Muneretto, C. (2023). Left Atrium Volume Reduction Procedure Concomitant With Cox-Maze Ablation in Patients Undergoing Mitral Valve Surgery: A Meta-Analysis of Clinical and Rhythm Outcomes. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2023.09.009

Vancouver

Baudo M, Rosati F, Di Bacco L, D'Alonzo M, Benussi S, Muneretto C. Left Atrium Volume Reduction Procedure Concomitant With Cox-Maze Ablation in Patients Undergoing Mitral Valve Surgery: A Meta-Analysis of Clinical and Rhythm Outcomes. Heart, Lung and Circulation. 2023. doi:10.1016/j.hlc.2023.09.009

BibTeX
@article{Baudo2023,
  author = {Baudo, Massimo and Rosati, Fabrizio and Di Bacco, Lorenzo and D'Alonzo, Michele and Benussi, Stefano and Muneretto, Claudio},
  title = {Left Atrium Volume Reduction Procedure Concomitant With Cox-Maze Ablation in Patients Undergoing Mitral Valve Surgery: A Meta-Analysis of Clinical and Rhythm Outcomes},
  journal = {Heart, Lung and Circulation},
  year = {2023},
  doi = {10.1016/j.hlc.2023.09.009}
}
Kostenlos starten →